Home › NDC Lookup › Ingredients › Maritime Pine, Schisandra Chinensis Seed... › 87130-0002-01
🧂image loading
(from DailyMed)

NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde MARITIME PINE, SCHISANDRA CHINENSIS SEED, CENTELLA ASIATICA TRITERPENOIDS 30 mg/6g; 90 mg/6g; 60 mg/6g Powder

by Japan Medical Biotechnology Limited · 10 BOTTLE in 1 BOX (87130-002-01) / 6 g in 1 BOTTLE
NDC 87130-0002-01
🏷️ FDA NDC (as labeled) 87130-002-01 billing pads the product segment with a zero
This package
Contains6 g in 1 bottle Pack sizes2 compare ↓
Also comes in: 90 bottles 87130-0002-02
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

🆔 Identity & classification

FDA NDC (as labeled) 87130-002-01
Product NDC 87130-002
11-digit billing NDC 87130000201
UNII 4YS74Q4G4J, 50JZ5Z98QY, MO9DK65G18
UPC 4595319021021
SPL Set ID 41a127d2-f717-3f9a-e063-6394a90a9123
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-10-20
Route ORAL
Dosage form POWDER
Substance CENTELLA ASIATICA TRITERPENOIDS; MARITIME PINE; SCHISANDRA CHINENSIS SEED
Why two NDCs? The FDA registers this code as 87130-002-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 87130-0002-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerJapan Medical Biotechnology Limited
Labeler code87130
First marketedOct 2025
Product typeHuman Otc Drug
Portfolio2 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

This is an unapproved oral powder containing maritime pine, schisandra chinensis seed, and centella asiatica triterpenoids. Maritime pine and schisandra are plant extracts commonly used in dietary supplements for their antioxidant properties, while centella asiatica triterpenoids are typically included in wellness products for skin health support. This product is marketed as an anti-aging skin renewal supplement but has not received FDA approval through a standard drug application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 90 bottles
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde 30 mg/6g; 90 mg/6g; 60 mg/6gthis 87130-0002-01 Japan 10 bottles — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

⏳ Availability & generic status

🏛️
2025
On the market since
Oct 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
87130-0002-01 You're viewing this 10 BOTTLE in 1 BOX (87130-002-01) / 6 g in 1 BOTTLE 2025-10-20 Active
87130-0002-02 90 BOTTLE in 1 BOX (87130-002-02) / 6 g in 1 BOTTLE 2025-10-20 Active

Pack size FAQ

What quantity is in NDC 87130-0002-01?
NDC 87130-0002-01 is listed by the FDA — 10 bottle in 1 box / 6 g in 1 bottle.
What NDC number is used to bill for this package of NEWSKIN Whole Embryonic Layer Anti-Aging Skin Renewal Powde MARITIME PINE, SCHISANDRA CHINENSIS SEED, CENTELLA ASIATICA TRITERPENOIDS 30 mg/6g; 90 mg/6g; 60 mg/6g Powder?
Bill NDC 87130-0002-01 — the 11-digit billing format is 87130000201. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 87130-002-01, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 87130-0002-01, written without dashes as 87130000201. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 87130-0002-01, the first segment (87130) is the labeler code FDA assigned to Japan Medical Biotechnology Limited; the middle segment (0002) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Japan Medical Biotechnology Limited. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 90 bottles (87130-0002-02). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Japan Medical Biotechnology Limited is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 110 words ▾

Uses Severe facial rhytides (wrinkles) due to cutaneous aging. Loss of facial structural support and reduction in bone-muscle precision attributable to skeletal aging. Facial laxity and infraorbital hollowing (sunken eyes) resulting from the aging of the adipose layer.

Targets the root cause by neutralizing key senescent factors. Provides comprehensive, multi-layered anti-aging therapy. Counters age-related bone resorption and bone mass loss (osteopenia).

Facilitates cellular repair to mitigate adipose tissue depletion and subsequent facial sagging. Restores damaged cells to reinforce the superficial musculoaponeurotic system (SMAS) and prevent dermal depression. Serves as a potent antioxidant to scavenge free radicals and protect mitochondrial integrity.

Provides protection against photoaging (dermal damage caused by ultraviolet radiation).

⏱️ Dosage and Administration 25 words ▾

Directions Ages 18-39: 6g every 12 hours; not more than 12g in 24hours Ages 40-65: 6g every 8 hours; not more than 18g in 24hours

⚠️ Warnings 107 words ▾

Warnings Not for use in pregnancy (except under medical supervision). Contraindicated in infants. Contraindicated in individuals with protein allergy.

Do not use if allergic to any ingredient in this formula. Ask a doctor or pharmacist before use if you are taking tranquilizers or sedatives When using this product GI discomfort: Bloating or nausea may occur. Allergic reactions: Rash or itching may occur in those allergic to seafood/botanical ingredients.

Photosensitivity: Rare cases of increased sun sensitivity. Sun protection advised. Ergotamine-related: May cause nausea, limb numbness.

Requires medical supervision. Keep out of reach of children. In case of overdose,get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 33 words ▾

Other information Reconstitute with warm water (86°F-131°F). Do not use boiling water (212°F) to prevent degradation of active ingredients and proteins. Store at 20-25°C (68-77°F) in a dry place protected from excessive moisture.

🧪 Active Ingredient 16 words ▾

Active ingredient（in each tablet） MARITIME PINE 90mg SCHIZANDRA CHINENSIS SEED EXTRACT 60mg CENTELLA ASIATICA TRITERPENOIDS 30mg

🧪 Inactive Ingredients 33 words ▾

Inactive ingredients Chlorella vulgaris, HYALURONATE SODIUM, CALCIUM PANTOTHENATE, MARINE COLLAGEN, SOLUBLE, SQUALENE, DOCOSAHEXAENOIC ACID, N-Acetyl-D-glucosamine, PHOSPHATIDYLSERINE, .ALPHA.-TOCOPHEROL, DISODIUM PYRROLOQUINOLINEDIONE TRICARBOXYLATE, ERGOTAMINE, WHEAT GERM, POMEGRANATE JUICE, STEVIA REBAUDIUNA LEAF EXTRACT, SILICON DIOXIDE, MICROCRYSTALLINE CELLULOSE

🎯 Purpose 12 words ▾

Purpose Potent Antioxidant Adaptogen & Hepatoprotective Agent Tissue Repair & Collagen Stimulant

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
← 87130-0001-01 · Japan 87131-0120-11 · Salvagenix →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.